LifeStance Health Q3 revenue beats on clinician growth, lifts FY outlook
LFST•LifeStance Health’s Q3 revenue rose 25% to $455.9 million, beating the $431.82 million estimate, while adjusted EBITDA increased 70% to $68.4 million. The company raised its 2026 revenue outlook to $1.741 billion-$1.761 billion and adjusted EBITDA outlook to $242 million-$250 million.
1. Q3 results
LifeStance Health reported Q3 revenue of $455.9 million and adjusted EBITDA of $68.4 million, beating analyst estimates of $431.82 million and $55.31 million, respectively. Net income was $22.4 million.
2. Raised outlook
The company raised its 2026 revenue outlook to $1.741 billion-$1.761 billion and adjusted EBITDA outlook to $242 million-$250 million. It expects Q4 revenue of $446 million-$466 million.
3. Growth drivers
LifeStance said revenue growth was driven primarily by higher visit volumes from net clinician growth, improved clinician productivity and higher total revenue per visit. It attributed the increase in adjusted EBITDA margin to higher revenue per visit, lower center costs as a percentage of revenue and improved operating leverage.
